Myriad Genetics (MYGN)
Entry: Unlock
Price target: 16.50-17.00
Second PT: Unlock
Myriad Genetics is a diagnostic company specializing in hereditary cancer, prenatal care, oncology, and mental health genetic testing. Their insights help detect, treat, and even prevent diseases, placing them at the intersection of healthcare innovation and personalized medicine.
In today’s world, where adults are having children later in life and where dual-income households are increasingly the norm, the demand for fertility treatments and prenatal care has grown substantially. The global fertility treatment market is projected to expand at a compound annual growth rate (CAGR) of 7-8% over the next decade, creating significant opportunities for companies operating in this space. Despite being a smaller player with relatively modest revenues, MYGN’s strategic involvement in this sector positions it as a potentially attractive stock.
What makes MYGN stand out is its dual focus on cancer diagnostics and prenatal treatments—two areas expected to draw significant attention this year. For instance, a recent statement from the U.S. Surgeon General highlighted the link between alcohol consumption and cancer, which has already sparked increased public interest in the field of cancer prevention and treatment. This surge in awareness could serve as a short-term catalyst for MYGN, amplifying its visibility and market potential.
However, the company’s appeal extends beyond short-term trends. MYGN’s long-term sustainability is likely to stem from its prenatal offerings, which address the growing demand for advanced reproductive care. With genetic testing playing a more prominent role in modern healthcare, MYGN’s ability to provide insights that support healthy pregnancies and proactive cancer treatments could drive consistent growth over time.
Given its involvement in two of the most dynamic and high-growth areas of healthcare, MYGN has earned a spot on our weekly watchlist. While the company’s current financial performance may be modest, its strategic positioning within these expanding markets makes it a stock worth watching closely in the months and years ahead.
Please note that this may take beyond this week to come around to price targets.
Okta (OKTA)
Entry: Unlock
Price target: 91.00-92.00
Second PT: Unlock
Okta earned a spot on our watchlist in August of last year, when we highlighted the company’s consistent growth and impressive outlook. Since then, Okta’s stock price has remained mostly unchanged, but its fundamentals have continued to improve. The company has reported two earnings since our initial analysis, both of which have been successful. However, the stock has been held back due to pessimism about the cybersecurity industry, which has experienced significant pullbacks in recent months. During this decline, companies like Palo Alto Networks, CrowdStrike, and others have suffered severe corrections, yet Okta has remained relatively stable. This resilience could be because Okta was already lagging behind the cybersecurity rally of 2024 and was trading at more reasonable valuation levels.
Re-examining their financials, we see that Okta’s $14.46 billion valuation represents a potentially attractive opportunity, particularly given its revenue growth. The company is on track to post another record annual revenue figure in its next earnings report and finally began posting positive net income in 2024. Although the 2024 fiscal year is not yet complete, projections indicate that Okta will achieve its first fully profitable year—a significant milestone. During this growth phase, management has maintained a healthy balance sheet, with $9 billion in assets and only $2.75 billion in liabilities. Additionally, free cash flow has grown to a solid $628 million, providing a buffer against unexpected expenses and enabling further investment in R&D.
Overall, Okta’s current performance and future projections suggest it could be a standout performer in 2025, especially if the company continues its strong execution and focuses on strategies that have proven successful.
Please note that this may take beyond this week to come around to price targets.
Roku, Inc. (ROKU)
Entry: Unlock
Price target: 86.00-88.00
Second PT: Unlock
Roku investors have experienced a turbulent journey over the past five years. The stock soared to a remarkable high of $490 during the 2020-2021 market rally, only to plummet to lows of $38 in subsequent years. Currently trading at $79, with a market capitalization of $11.50 billion, Roku appears undervalued when assessed against its improving financial metrics.
The lofty highs reached during the 2020-2021 rally ultimately proved detrimental, as they heightened investor caution and led to an extended period of correction. However, Roku has remained steadfast in strengthening its business fundamentals. Since 2020, revenue has grown from $1.78 billion to nearly $4 billion in 2023. Meanwhile, net income has transitioned from significant losses to approaching breakeven, with the latest quarter showing the fourth consecutive earnings beat. Despite these achievements, the stock price has remained relatively flat over the past year.
While Roku’s financial growth may not be exponential, the company is clearly progressing in the right direction. Its balance sheet reflects a healthy asset-to-liability ratio, and free cash flow has turned positive—a crucial indicator of operational stability. The company’s most promising opportunity lies in achieving consistent positive net income. If Roku manages to cross into profitability this year, it could catalyze a bullish rally, reigniting investor confidence.
Please note that this may take beyond this week to come around to price targets.
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information.
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information.
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information.
___________________________________
The stocks posted above are the preliminary stocks and set ups we’ll be watching this week. All price points are subject to change based on market performance and sector health. Please do your own research and analysis on these companies/charts before taking on any set ups. Trade at your own risk and as always, good luck! Let’s have a fantastic week.